Matteo Garcovich
- Hepatology top 1%
- Liver Disease and Transplantation 26
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Hepatitis C virus research 5
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 35
- Gastroenterology top 10%
- Internal Medicine top 10%
- Surgery top 10%
- Organ Transplantation Techniques and Outcomes 7
- Pancreatitis Pathology and Treatment 4
-
- MRI in cancer diagnosis 5
-
- Pancreatic and Hepatic Oncology Research 5
- Co-authors
- Antonio GasbarriniMaria Assunta ZoccoMaurizio PompiliMaria Elena AinoraAndrew K. BurroughsLaura RiccardiJames O’BeirneEmmanuel Tsochatzis
- Partner nations
- ItalyUnited KingdomJapan
In The Last Decade
Matteo Garcovich
62 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 95
- Hepatology 629
- Epidemiology 527
- Gastroenterology 57
- Internal Medicine 34
- Surgery 288
Countries citing papers authored by Matteo Garcovich
This map shows the geographic impact of Matteo Garcovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Garcovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Garcovich more than expected).
Fields of papers citing papers by Matteo Garcovich
This network shows the impact of papers produced by Matteo Garcovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Garcovich. The network helps show where Matteo Garcovich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matteo Garcovich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 7 | |
| 11 | 2019 | 38 | |
| 12 | 2018 | 27 | |
| 13 | 2018 | 24 | |
| 14 | Toxicity and risks from drug-to-drug interactions of new antivirals for chronic hepatitis C. | 2017 | 6 |
| 15 | 2016 | 46 | |
| 16 | 2014 | 28 | |
| 17 | 2012 | 39 | |
| 18 | 2012 | 9 | |
| 19 | 2011 | 0 | |
| 20 | 2011 | 47 |
About Matteo Garcovich
Matteo Garcovich is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (35 papers), Liver Disease and Transplantation (26 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Organ Transplantation Techniques and Outcomes (7 papers), MRI in cancer diagnosis (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Hepatitis C virus research (5 papers) and Pancreatitis Pathology and Treatment (4 papers). The work is most often cited by research in Hepatology (629 citations), Epidemiology (527 citations) and Gastroenterology (57 citations). Matteo Garcovich has collaborated with scholars based in Italy, United Kingdom and Japan. Frequent co-authors include Antonio Gasbarrini, Maria Assunta Zocco, Maurizio Pompili, Maria Elena Ainora, Andrew K. Burroughs, Laura Riccardi, James O’Beirne, Emmanuel Tsochatzis, Francesca Romana Ponziani and Enrico Di Stasio. Their work appears in journals such as Gastroenterology, Hepatology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.